feed,title,long_url,short_url
gNews,GILD Stock: Gilead Snags Approval For A Twice-Yearly HIV Treatment | Investor's Business Daily - Investor's Business Daily,https://www.investors.com/news/technology/gild-stock-gilead-snags-approval-for-a-twice-yearly-hiv-treatment/,https://da.gd/jhCJbc
gNews,US stock market 2023 outlook: Can a soft landing still be achieved? - Capital.com,https://capital.com/us-stock-market-2023-outlook-can-a-soft-landing-still-be-achieved,https://da.gd/RUrRhA
